Vitiligo News

An in-depth interview about the effects of the CMS’s 2025 physician fee schedule on patient access topped Healio Dermatology’s most-read articles of November, with FDA news also garnering attention.

The CMS finalized cuts to the 2025 physician fee schedule for the fifth year in a row, prompting an urgent call-to-action from the American Academy of Dermatology. HHS, through the CMS, announced the finalization of the 2025 Medicare Physician Fee Schedule.

A study on cancer-causing benzene in acne products was Healio Dermatology’s most-read article of October, with coverage from clinical meetings also garnering attention.

ORLANDO — Autologous skin cell suspension using RECELL was an effective and safe treatment for patients with stable vitiligo, according to a presentation at the American Society for Dermatologic Surgery Annual Meeting.

ORLANDO — Tattoos are not just for decorative purposes; they can also be used to treat vitiligo, according to a presentation at the American Society for Dermatologic Surgery Annual Meeting.

Celebrity news and nutrition stories led Healio Dermatology’s most-read articles in August.

Autologous skin cell suspension transplantation using a cell harvesting device was shown to be effective and well tolerated in vitiligo treatment, according to a study.

Beneath the Surface is a video series in which Joel M. Gelfand, MD, MSCE, Healio Dermatology Chief Medical Editor, discusses hot topics in the field with leading experts.

With Kim Kardashian speaking out about her son’s experience with vitiligo, Healio Dermatology sat with an expert to discuss the condition in the adult and pediatric populations.